Ontology type: schema:ScholarlyArticle
2019-03-06
AUTHORSUlrich Ronellenfitsch, Ioannis Karampinis, Antonia Dimitrakopoulou-Strauss, Christos Sachpekidis, Jens Jakob, Bernd Kasper, Kai Nowak, Lothar Pilz, Ulrike Attenberger, Timo Gaiser, Hans-Günther Derigs, Matthias Schwarzbach, Peter Hohenberger
ABSTRACTBACKGROUND: Preoperative devascularization might improve local control and thus the outcome of patients with soft tissue sarcoma (STS). The multikinase inhibitor pazopanib has antiangiogenic effects and is approved for treating metastatic STS. We conducted a trial of preoperative pazopanib therapy in high-risk STS. METHODS: This single-arm, phase II trial included patients with resectable, non-metastatic, treatment-naïve, high-risk STS. Patients received pazopanib 800 mg daily while waiting for surgery (21-day 'window of opportunity'). The primary endpoint was metabolic response rate (MRR; proportion of patients with ≥ 50% reduction of mean standardized uptake value [SUVmean] in post- vs. pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography [FDG-PET-CT]). Planned sample size was 35 patients (type I error, 5%; type II error, 20%). A translational substudy explored associations between response and concentration of circulating angiogenic factors. RESULTS: Futility analysis was performed after 21 patients (11 female, mean age 67 years; liposarcoma n = 15); 17/21 patients were evaluable for the primary endpoint. The MRR was 1/17 (5.9%, 95% confidence interval < 0.01-0.29). Mean change in SUVmean of post- versus pretreatment PET was a 6% decrease (range 65% decrease to 34% increase); 7/21 (33.3%) patients had 12 grade 3/4 toxicities, and 19/21 (95.2%) patients were resected (all R0). One (4.8%) patient suffered a grade 4 postoperative complication (anastomotic leakage). Circulating endothelial progenitor cells, soluble vascular endothelial growth factor, and angiopoietin-2 concentrations showed no relevant changes during treatment. CONCLUSIONS: Although this study showed that preoperative pazopanib is not effective for unselected high-risk STS patients, relevant treatment effects were observed in a single patient. Future research needs to better define subgroups potentially benefiting from preoperative pazopanib treatment. CLINICALTRIALS. GOV IDENTIFIER: NCT01543802. More... »
PAGES1-8
http://scigraph.springernature.com/pub.10.1245/s10434-019-07183-4
DOIhttp://dx.doi.org/10.1245/s10434-019-07183-4
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1112585965
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/30843160
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "University Medical Centre Mannheim",
"id": "https://www.grid.ac/institutes/grid.411778.c",
"name": [
"Department of Vascular Surgery and Endovascular Surgery, University Hospital Heidelberg, Heidelberg, Germany",
"Division of Surgical Oncology and Thoracic Surgery, University Medical Center Mannheim, Mannheim, Germany"
],
"type": "Organization"
},
"familyName": "Ronellenfitsch",
"givenName": "Ulrich",
"type": "Person"
},
{
"affiliation": {
"alternateName": "University Medical Centre Mannheim",
"id": "https://www.grid.ac/institutes/grid.411778.c",
"name": [
"Division of Surgical Oncology and Thoracic Surgery, University Medical Center Mannheim, Mannheim, Germany"
],
"type": "Organization"
},
"familyName": "Karampinis",
"givenName": "Ioannis",
"type": "Person"
},
{
"affiliation": {
"alternateName": "German Cancer Research Center",
"id": "https://www.grid.ac/institutes/grid.7497.d",
"name": [
"Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany"
],
"type": "Organization"
},
"familyName": "Dimitrakopoulou-Strauss",
"givenName": "Antonia",
"type": "Person"
},
{
"affiliation": {
"alternateName": "German Cancer Research Center",
"id": "https://www.grid.ac/institutes/grid.7497.d",
"name": [
"Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany"
],
"type": "Organization"
},
"familyName": "Sachpekidis",
"givenName": "Christos",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Universit\u00e4tsmedizin G\u00f6ttingen",
"id": "https://www.grid.ac/institutes/grid.411984.1",
"name": [
"Division of Surgical Oncology and Thoracic Surgery, University Medical Center Mannheim, Mannheim, Germany",
"Department of General, Visceral and Child Surgery, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany"
],
"type": "Organization"
},
"familyName": "Jakob",
"givenName": "Jens",
"type": "Person"
},
{
"affiliation": {
"name": [
"Interdisciplinary Tumor Center MannheimSarcoma Unit, Mannheim University Medical Center, Mannheim, Germany"
],
"type": "Organization"
},
"familyName": "Kasper",
"givenName": "Bernd",
"type": "Person"
},
{
"affiliation": {
"alternateName": "University Medical Centre Mannheim",
"id": "https://www.grid.ac/institutes/grid.411778.c",
"name": [
"Division of Surgical Oncology and Thoracic Surgery, University Medical Center Mannheim, Mannheim, Germany",
"Department of Abdominal, Vascular and Thoracic Surgery, Romed Klinikum, Rosenheim, Germany"
],
"type": "Organization"
},
"familyName": "Nowak",
"givenName": "Kai",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Heidelberg University",
"id": "https://www.grid.ac/institutes/grid.7700.0",
"name": [
"Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany"
],
"type": "Organization"
},
"familyName": "Pilz",
"givenName": "Lothar",
"type": "Person"
},
{
"affiliation": {
"alternateName": "University Medical Centre Mannheim",
"id": "https://www.grid.ac/institutes/grid.411778.c",
"name": [
"Institute of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Mannheim, Germany"
],
"type": "Organization"
},
"familyName": "Attenberger",
"givenName": "Ulrike",
"type": "Person"
},
{
"affiliation": {
"alternateName": "University Medical Centre Mannheim",
"id": "https://www.grid.ac/institutes/grid.411778.c",
"name": [
"Institute of Pathology, University Medical Center Mannheim, Mannheim, Germany"
],
"type": "Organization"
},
"familyName": "Gaiser",
"givenName": "Timo",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Johannes Gutenberg University of Mainz",
"id": "https://www.grid.ac/institutes/grid.5802.f",
"name": [
"Department of Hematology and Oncology, Klinikum Frankfurt-Hoechst, Frankfurt am Main, Germany"
],
"type": "Organization"
},
"familyName": "Derigs",
"givenName": "Hans-G\u00fcnther",
"type": "Person"
},
{
"affiliation": {
"name": [
"Department of Surgery, Klinikum Frankfurt-Hoechst, Frankfurt am Main, Germany"
],
"type": "Organization"
},
"familyName": "Schwarzbach",
"givenName": "Matthias",
"type": "Person"
},
{
"affiliation": {
"alternateName": "University Medical Centre Mannheim",
"id": "https://www.grid.ac/institutes/grid.411778.c",
"name": [
"Division of Surgical Oncology and Thoracic Surgery, University Medical Center Mannheim, Mannheim, Germany"
],
"type": "Organization"
},
"familyName": "Hohenberger",
"givenName": "Peter",
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1002/sim.721",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1001557237"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1080/0284186x.2016.1234068",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1008597454"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.2967/jnumed.108.053694",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1008860668"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.2967/jnumed.109.070862",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1014018031"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/annonc/mdq622",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1018816765"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1078-0432.ccr-08-2537",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020222505"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1634/theoncologist.2007-0165",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020982260"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa020461",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022255922"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1634/theoncologist.2009-0274",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1025545454"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ejca.2008.10.026",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026558254"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/cncr.29991",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031049265"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1136/bmjopen-2015-009558",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031620962"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.bbcan.2009.04.006",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034706238"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3109/0284186x.2015.1037404",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034949334"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ejca.2016.09.030",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037275084"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0140-6736(12)60651-5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040046880"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10456-009-9160-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040167422",
"https://doi.org/10.1007/s10456-009-9160-6"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10456-009-9160-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040167422",
"https://doi.org/10.1007/s10456-009-9160-6"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1078-0432.ccr-06-0919",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042102174"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/annonc/mdt586",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044198149"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1078-0432.ccr-07-1762",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045267524"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1001/jamaoncol.2016.1197",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047481384"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/cncr.20769",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048393114"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2008.21.3223",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1049371010"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/annonc/mdh309",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052724218"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1077319754",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1077813950",
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ijrobp.2017.02.087",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1083909086"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s1470-2045(17)30334-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1085380791"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/cncr.30926",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1091238439"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ejso.2018.01.083",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1100773268"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1001/jamaoncol.2017.4996",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1101055676"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1001/jamaoncol.2017.4996",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1101055676"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1001/jamaoncol.2018.1392",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1104461229"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/annonc/mdy321",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1107413557"
],
"type": "CreativeWork"
}
],
"datePublished": "2019-03-06",
"datePublishedReg": "2019-03-06",
"description": "BACKGROUND: Preoperative devascularization might improve local control and thus the outcome of patients with soft tissue sarcoma (STS). The multikinase inhibitor pazopanib has antiangiogenic effects and is approved for treating metastatic STS. We conducted a trial of preoperative pazopanib therapy in high-risk STS.\nMETHODS: This single-arm, phase II trial included patients with resectable, non-metastatic, treatment-na\u00efve, high-risk STS. Patients received pazopanib 800\u00a0mg daily while waiting for surgery (21-day 'window of opportunity'). The primary endpoint was metabolic response rate (MRR; proportion of patients with \u2265\u00a050% reduction of mean standardized uptake value [SUVmean] in post- vs. pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography [FDG-PET-CT]). Planned sample size was 35 patients (type I error, 5%; type II error, 20%). A translational substudy explored associations between response and concentration of circulating angiogenic factors.\nRESULTS: Futility analysis was performed after 21 patients (11 female, mean age 67\u00a0years; liposarcoma n\u00a0=\u00a015); 17/21 patients were evaluable for the primary endpoint. The MRR was 1/17 (5.9%, 95% confidence interval <\u00a00.01-0.29). Mean change in SUVmean of post- versus pretreatment PET was a 6% decrease (range 65% decrease to 34% increase); 7/21 (33.3%) patients had 12 grade 3/4 toxicities, and 19/21 (95.2%) patients were resected (all R0). One (4.8%) patient suffered a grade 4 postoperative complication (anastomotic leakage). Circulating endothelial progenitor cells, soluble vascular endothelial growth factor, and angiopoietin-2 concentrations showed no relevant changes during treatment.\nCONCLUSIONS: Although this study showed that preoperative pazopanib is not effective for unselected high-risk STS patients, relevant treatment effects were observed in a single patient. Future research needs to better define subgroups potentially benefiting from preoperative pazopanib treatment. CLINICALTRIALS.\nGOV IDENTIFIER: NCT01543802.",
"genre": "research_article",
"id": "sg:pub.10.1245/s10434-019-07183-4",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1105545",
"issn": [
"1068-9265",
"1534-4681"
],
"name": "Annals of Surgical Oncology",
"type": "Periodical"
},
{
"issueNumber": "5",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "26"
}
],
"name": "Preoperative Pazopanib in High-Risk Soft Tissue Sarcoma: Phase II Window-of Opportunity Study of the German Interdisciplinary Sarcoma Group (NOPASS/GISG-04)",
"pagination": "1-8",
"productId": [
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1245/s10434-019-07183-4"
]
},
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"5107608c1edefb5f6cb105d22fc8aa9a6a679db5c6d5374eb9fbbac2201cb3c7"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1112585965"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"9420840"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"30843160"
]
}
],
"sameAs": [
"https://doi.org/10.1245/s10434-019-07183-4",
"https://app.dimensions.ai/details/publication/pub.1112585965"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-15T09:00",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000375_0000000375/records_91441_00000001.jsonl",
"type": "ScholarlyArticle",
"url": "https://link.springer.com/10.1245%2Fs10434-019-07183-4"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1245/s10434-019-07183-4'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1245/s10434-019-07183-4'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1245/s10434-019-07183-4'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1245/s10434-019-07183-4'
This table displays all metadata directly associated to this object as RDF triples.
259 TRIPLES
21 PREDICATES
61 URIs
20 LITERALS
9 BLANK NODES